Click Here For Register Register Now
Topic: Management of status asthmaticus in pediatric patient 8:15am-9:15am
Speaker: Lynn Nguyen Pharm.D PGY-2 Pediatric Pharmacy Resident New York-Presbyterian Hospital Enterprise
Learning Objectives:
- Describe the general treatment algorithm for status asthmaticus including the first line and escalation
pharmacologic therapies. - Explain the role of ipratropium in the treatment of status asthmaticus using clinical evidence and literature.
- Identify evidence supporting escalation therapies in status asthmaticus and potential adverse effects to the
pediatric population
Topic: USP General Chapters <795>, <797>, <800> An Overview of The New Chapters 9:30am -12:30pm
Speaker: Joseph Navarra Pharm.D Town Total Compounding Center
Learning Objectives:
- Current New York State Board of Pharmacy regulations
- Required standards for non-sterile and sterile compounding
- Compliance expectations under USP <795>, <797>, and <800>
- Facility, documentation, and quality-assurance requirements
- Oversight, inspection trends, and best practices for maintaining regulatory readiness
Topic: Direct Oral Anticoagulation (DOAC): Safe and Effective Anticoagulation 1:15pm – 2:15pm
Speaker: Jasmeen Hussain Pharm.D
Learning Objectives:
- understanding DOAC mechanisms of action
- comparing indications/dosing/frequency/side effects/contraindications/monitoring parameters
- Identify patient specific factors (renal function, age, weight, indication) that determine DOAC selection and dosing
- Recognize and manage drug to drug interactions with DOACs
- Discuss patient counseling points
- Review Guideline Recommendations
Topic: Skin Under Stress: Managing Dermatologic Adverse Effects of Cancer Therapy 2:15pm-3:15pm
Speaker: Zainab Javed Pharm.D
Learning Objectives:
- Identify common dermatologic adverse effects associated with cancer therapies, including xerosis, pruritus, acneiform eruptions, hand-foot syndrome, radiation dermatitis, nail changes, and alopecia.
- Differentiate dermatologic toxicities associated with major cancer treatment modalities, including chemotherapy, targeted therapies, immunotherapy, and radiation therapy.
- Describe evidence-based strategies for the prevention and management of treatment-related skin toxicities, including pharmacologic and supportive skincare interventions.
- Demonstrate the pharmacist’s role in educating patients, promoting adherence, and collaborating with the multidisciplinary care team to minimize the impact of dermatologic adverse effects on quality of life and continuity of cancer therapy.
Contact:
Shahbaz Khan 207-299-5289
Muhammad Asghar Chuhan 917-686-0246
Samar Shamsi Rehman 917-755-8428
Syed Nasimur Rahman 914-337-3780
Bilal Qureshi 718-795-3739
Registration:
Zoom link & St. Jon’s Link will be available on our website
Via website www.papausa.com
Paid Members Free 2026
Non-Members Fee $250.00
St. John’s University College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education.